Anish Mehta
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Bone health and treatments, Radiopharmaceutical Chemistry and Applications, Acute Ischemic Stroke Management, Bone Metabolism and Diseases
Most-Cited Works
- → The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial(2010)144 cited
- → Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs – midazolam and odanacatib(2014)22 cited
- → Factors contributing to disparities in mortality among patients with non–small‐cell lung cancer(2018)14 cited
- → Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy Subjects(2016)3 cited
- → E-200 Gender and racial disparity in outcome of aneurysmal subarachnoid hemorrhage in the united states(2020)1 cited
- → OC2. Efficacy, pharmacokinetics, and safety of a cathepsin K (Cat K) inhibitor in the suppression of bone resorption in women with breast cancer and established bone 2(2008)1 cited
- → Potential Hydrokinetic Turbine Installation Site Selection in Canal Using Various Turbulence Models(2025)
- → Abstract 181: Acute Ischemic Stroke And Endovascular Thrombectomy During COVID‐19 Pandemic: A Nationwide Analysis(2024)
- → A Subgroup Analysis Of A 12-month, Open-label Study To Evaluate Add-on Montelukast In Asthma Patients(2010)
- → Issue Information(2016)